Every NR4A2 paper, in plain English

Moracenin D from Mori Cortex radicis protects SH-SY5Y cells against dopamine-induced cell death by regulating nurr1 and α-synuclein expression.

Ham A, Lee HJ, Hong SS, Lee D, Mar W

Moracenin D, a compound derived from mulberry root, protects human neuroblastoma cells from dopamine-induced death by increasing Nurr1 levels and decreasing alpha-synuclein. This study provides only preclinical evidence in cell lines with no established path to clinical treatment for NR4A2-related syndromes.

• Moracenin D protects SH-SY5Y neuroblastoma cells from dopamine toxicity.
• Treatment upregulates Nurr1 mRNA and protein expression in these cells.
• Treatment downregulates alpha-synuclein mRNA and protein expression.
• The study uses human cell lines, not animal models or patients.
• No clinical trials or human data support this finding for NR4A2.

NR4A gene expression is dynamically regulated in the ventral tegmental area dopamine neurons and is related to expression of dopamine neurotransmission genes.

Eells JB, Wilcots J, Sisk S, Guo-Ross SX

Dopamine neuron activity directly controls the levels of NR4A2 (Nurr1) and related genes in mouse brain tissue. Blocking dopamine signals changes these gene levels, which in turn influences the expression of key enzymes and transporters needed for dopamine function.

• NR4A2 levels depend on active dopamine signaling in mouse ventral tegmental area neurons.
• Blocking dopamine receptors increases NR4A1 (Nur77) but decreases NR4A2 in mice.
• Haloperidol treatment boosts NR4A1 and NR4A3, increasing dopamine enzyme expression.
• NR4A genes dynamically regulate dopamine neurotransmission machinery in response to neuronal activity.

Altered layer-specific gene expression in cortical samples from patients with temporal lobe epilepsy.

Rossini L, Moroni RF, Tassi L, Watakabe A, Yamamori T, Spreafico R, Garbelli R

This study examines how specific genes are expressed in the brain tissue of patients with temporal lobe epilepsy to understand the structural abnormalities associated with the condition. It identifies that NURR1 (NR4A2) and other layer-specific markers show altered distribution patterns in epileptic cortical dysplasia compared to normal brain tissue. The findings suggest that disruptions in deep cortical neuron organization are a common feature of these developmental brain malformations.

• Researchers analyzed gene expression in surgical brain samples from temporal lobe epilepsy patients.
• NURR1 and ER81 showed altered distribution in deeper cortical layers of epileptic tissue.
• Atypical coexpression of NURR1 and CUX2 was found in specific neuronal aggregates.
• Layer-specific genes help identify developmental defects in cortical dysplasia pathology.

Nurr1 is not essential for the development of prepulse inhibition deficits induced by prenatal immune activation.

Vuillermot S, Feldon J, Meyer U

This mouse study shows that Nurr1 is not required for the development of specific behavioral deficits caused by prenatal immune challenges. The findings indicate that other molecular pathways, rather than Nurr1 itself, drive these particular neurodevelopmental outcomes in this model.

• Prenatal immune activation causes prepulse inhibition deficits in adult mice regardless of Nurr1 levels.
• Nurr1 deletion does not prevent behavioral abnormalities induced by maternal inflammation in this mouse model.
• The study uses a heterozygous Nurr1 knockout mouse to test the role of this gene.
• Results suggest Nurr1 is not the critical mediator for these specific immune-induced deficits.

Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.

Datta I, Mishra S, Mohanty L, Pulikkot S, Joshi PG

This study shows that mesenchymal stem cells from umbilical cord tissue can be converted into dopamine-producing neurons in the lab, performing similarly to bone marrow stem cells. The research confirms these cells express key dopaminergic markers and release dopamine when stimulated. This work does not involve human patients or NR4A2 genetics.

• Umbilical cord stem cells differentiate into dopamine-producing neurons in vitro.
• Differentiation efficiency matches that of bone marrow stem cells.
• Induced cells express Nurr1 and other dopaminergic markers.
• Stimulated cells release dopamine, mimicking neuronal function.
• No human clinical data or NR4A2 genetic analysis included.

Human embryonic stem cell proliferation and differentiation as parameters to evaluate developmental toxicity.

Pal R, Mamidi MK, Das AK, Bhonde R

This study used human embryonic stem cells to test how toxic drugs affect early development, showing that certain drugs disrupt cell growth, cause cell death, and interfere with the formation of key tissues like brain and liver. The results suggest a more accurate way to predict developmental toxicity in humans than older methods.

• Human stem cells detect drug effects on early development
• Drugs reduced cell survival and disrupted tissue formation
• Changes in gene and protein levels reflect impaired development
• New testing method may replace outdated models
• Findings could improve safety testing for pregnant women

Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration.

Maijenburg MW, Gilissen C, Melief SM, Kleijer M, Weijer K, Ten Brinke A, Roelofs H, Van Tiel CM, Veltman JA, de Vries CJ, van der Schoot CE, Voermans C

This study shows that NR4A2 (Nurr1) and its relative Nur77 increase the movement of mesenchymal stromal cells in laboratory settings. The research focuses on how these genes affect stem cell migration and immune signaling rather than brain development or neurological symptoms.

• NR4A2 and Nur77 boost the migration of bone marrow stem cells toward specific chemical signals.
• These genes alter cytokine production but do not impair the cells' ability to suppress T-cell activity.
• The findings apply only to mesenchymal stromal cells, not dopaminergic neurons or brain tissue.
• No human clinical data or NR4A2 patient phenotypes are included in this research.

Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues.

Demura M, Wang F, Yoneda T, Karashima S, Mori S, Oe M, Kometani M, Sawamura T, Cheng Y, Maeda Y, Namiki M, Ino H, Fujino N, Uchiyama K, Tsubokawa T, Yamagishi M, Nakamura Y, Ono K, Sasano H, Demura Y, Takeda Y

This study maps how the NR4A2 gene uses different starting points to create mRNA in heart and adrenal tissues, finding that these patterns differ between healthy tissue and diseased states like aldosterone-producing adenomas. It does not identify new mutations or clinical outcomes for children with NR4A2-related syndromes.

• NR4A2 uses multiple alternative promoters in cardiovascular and adrenal tissues.
• Promoter usage differs significantly between adrenal adenomas and arteries.
• The study focuses on gene regulation mechanisms, not human genetics or clinical phenotypes.
• No data on NR4A2 variants, patient symptoms, or treatment responses is provided.

Differential regulation of Nr4a subfamily nuclear receptors following mast cell activation.

Lundequist A, Calounova G, Wensman H, Rönnberg E, Pejler G

Mast cells, immune cells involved in allergic and inflammatory responses, increase production of NR4A family proteins—especially NR4A3—when activated by bacteria, immune signals, or allergens. This suggests NR4A proteins may help control mast cell activity, potentially influencing conditions like allergies or inflammation.

• NR4A3 is strongly upregulated in activated mast cells
• NR4A proteins increase in response to bacterial and allergic triggers
• NR4A3 induction depends on specific signaling pathways
• Human mast cells also show this response
• NR4A proteins may regulate mast cell function

Schizophrenia-relevant behaviors in a genetic mouse model of constitutive Nurr1 deficiency.

Vuillermot S, Joodmardi E, Perlmann T, Ove Ögren S, Feldon J, Meyer U

Mice with reduced Nurr1 levels show specific behavioral changes resembling aspects of schizophrenia, such as increased movement and sensory processing issues. These findings confirm that Nurr1 is critical for normal brain development but do not provide direct evidence for treating NR4A2-related syndromes in children.

• Mice with one copy of the Nurr1 gene show increased spontaneous movement.
• Male mice exhibit deficits in sensory gating, a measure of attention filtering.
• The study uses a mouse model, not human patients or clinical data.
• Results link Nurr1 to dopaminergic development but offer no treatment insights.

Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms.

Le-Niculescu H, Balaraman Y, Patel SD, Ayalew M, Gupta J, Kuczenski R, Shekhar A, Schork N, Geyer MA, Niculescu AB

This study identifies NR4A2 as one of several candidate genes associated with anxiety disorders by integrating data from human genetics and mouse models. The research highlights shared genetic mechanisms between anxiety, bipolar disorder, and schizophrenia, suggesting a broad overlap in their molecular underpinnings.

• NR4A2 appears among top candidate genes for anxiety disorders in this translational study.
• The findings link anxiety to bipolar disorder and schizophrenia through shared genetic pathways.
• The study uses mouse models and human data to identify potential blood biomarkers.
• Results suggest a new 'schizo-anxiety' domain due to significant genetic overlap.

Transplantation of neuronal-primed human bone marrow mesenchymal stem cells in hemiparkinsonian rodents.

Khoo ML, Tao H, Meedeniya AC, Mackay-Sim A, Ma DD

Human bone marrow stem cells can be guided toward immature neuron-like cells in the lab, but they do not survive long or turn into neurons after being transplanted into the brains of Parkinson's-like rats, even with immune suppression. Inflammation around the transplant site likely prevents long-term survival, suggesting that calming this response may be key to future success.

• hMSCs become neuron-like in lab but don’t survive long in brain
• No evidence of stem cells turning into neurons or helping brain repair
• Inflammation around grafts likely blocks survival
• Previous methods like priming or co-transplantation didn’t help
• Reducing brain inflammation may be essential for success

Transcription Mapping of Embryonic Rat Brain Reveals EGR-1 Induction in SOX2 Neural Progenitor Cells.

Wells T, Rough K, Carter DA

EGR-1, a gene involved in brain development, is active in early brain stem cells (SOX2+ cells) in rats during late embryonic stages, suggesting it helps regulate how these cells develop. This finding reveals a new role for EGR-1 in neural progenitor cells, potentially influencing brain organization before birth.

• EGR-1 is active in SOX2+ neural stem cells during late embryonic development
• EGR-1 may help regulate brain cell development through interaction with SOX2
• This activity occurs in key brain zones like the subplate and intermediate zones
• EGR-1's expression is controlled by positive regulatory elements, not silencers
• Findings suggest EGR-1 plays a role in organizing brain structure before birth

Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease.

Zhang L, Le W, Xie W, Dani JA

This study uses mice to show that reduced Nurr1 levels impair dopamine release and signaling before significant neuron loss occurs. The findings describe the biological mechanism of dopamine decline in a Parkinson's disease model but do not involve human patients or clinical treatments.

• Nurr1 deficiency impairs dopamine release before neurons die.
• The study uses heterozygous Nurr1 knockout mice as a model.
• Results focus on preclinical molecular mechanisms of dopamine decline.
• No human data or clinical trial results are presented.

Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease.

Castillo V, Theodoropoulou M, Stalla J, Gallelli MF, Cabrera-Blatter MF, Haedo MR, Labeur M, Schmid HA, Stalla GK, Arzt E

Pasireotide reduces ACTH and cortisol levels while shrinking pituitary tumors in dogs with Cushing's disease. The drug works by suppressing hormone production through specific receptor pathways, showing potential for treating similar conditions in humans.

• Pasireotide lowers ACTH and cortisol in dogs with spontaneous Cushing's disease.
• Treatment shrinks pituitary adenoma size without side effects over six months.
• The drug inhibits hormone synthesis via SSTR2 receptor signaling mechanisms.
• Results suggest pasireotide may be a viable therapy for human Cushing's disease.

Chronic methamphetamine administration causes differential regulation of transcription factors in the rat midbrain.

Krasnova IN, Ladenheim B, Hodges AB, Volkow ND, Cadet JL

Toxic doses of methamphetamine reduce the expression of Nurr1 (NR4A2) and other developmental transcription factors in the rat midbrain, which may contribute to dopamine neuron vulnerability. Pretreatment with lower doses of methamphetamine alters this response by increasing protective factors like Otx2 and Pitx3, potentially shielding against subsequent dopamine depletion.

• Methamphetamine toxicity decreases Nurr1 expression in adult rat brains.
• Pre-exposure to methamphetamine changes how developmental genes respond to later toxic doses.
• Increased Otx2 and Pitx3 levels may protect against dopamine loss after drug exposure.
• This study uses a rat model of drug neurotoxicity, not human patients.

Inflammation: a role for NR4A orphan nuclear receptors?

McMorrow JP, Murphy EP

This review describes how NR4A2 helps regulate immune responses in chronic inflammatory diseases like rheumatoid arthritis and psoriasis. It explains that these receptors act as switches for cytokine signaling but does not provide information on movement disorders or treatments for NR4A2-related syndrome.

• NR4A2 regulates immune cell activity in chronic inflammation.
• The paper focuses on rheumatoid arthritis, psoriasis, and atherosclerosis.
• It reviews molecular mechanisms without clinical data for NR4A2 syndrome.
• No specific treatments or genetic findings for this child are discussed.

Loss of braking signals during inflammation: a factor affecting the development and disease course of multiple sclerosis.

Gilli F, Navone ND, Perga S, Marnetto F, Caldano M, Capobianco M, Pulizzi A, Malucchi S, Bertolotto A

This study measures NR4A2 gene expression in the blood of adults with multiple sclerosis to understand immune system regulation. It finds that lower NR4A2 levels correlate with more severe disease activity, but the gene's expression does not change in response to standard MS treatments.

• NR4A2 levels drop in MS patients and correlate with higher relapse rates.
• Lower NR4A2 also links to greater disability progression over time.
• Standard MS therapies do not alter NR4A2 expression levels.
• The study focuses on adult multiple sclerosis, not pediatric neurodevelopment.
• NR4A2 acts as a negative regulator of inflammation in this context.

Network-like impact of MicroRNAs on neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood.

Iwaniuk KM, Schira J, Weinhold S, Jung M, Adjaye J, Müller HW, Wernet P, Trompeter HI

This study identifies a network of microRNAs that regulate the differentiation of stem cells into dopamine-producing neurons. It maps how these microRNAs control specific proteins involved in neuronal development and signaling pathways.

• Stem cells from cord blood differentiate into dopamine-releasing neurons expressing Nurr1.
• Eighteen microRNAs downregulate during this neuronal lineage differentiation process.
• These microRNAs target genes in axon guidance and WNT, MAPK signaling pathways.
• Experimental validation confirms the role of these targets in neuronal function.

Cross-talk between NR4A orphan nuclear receptors and β-catenin signaling pathway in osteoblasts.

Rajalin AM, Aarnisalo P

NR4A receptors, including Nurr1, suppress the activity of β-catenin in bone-forming cells, which may affect bone development and function. This interaction occurs through DNA binding and does not involve direct protein contact or changes in β-catenin levels.

• NR4A receptors block β-catenin activity in bone cells
• The effect happens through DNA binding, not protein interaction
• β-catenin also reduces NR4A receptor activity
• This crosstalk may influence bone formation and disease
• No change in β-catenin protein levels was observed

Comparative aspects of subplate zone studied with gene expression in sauropsids and mammals.

Wang WZ, Oeschger FM, Montiel JF, García-Moreno F, Hoerder-Suabedissen A, Krubitzer L, Ek CJ, Saunders NR, Reim K, Villalón A, Molnár Z

This study maps where NR4A2 (Nurr1) and related genes are located in the brains of turtles, chicks, opossums, mice, and rats to understand brain evolution. It finds that these markers appear in different brain regions across species, suggesting they were present in a common ancestor. The research provides no information on human disease, treatment, or the specific symptoms of NR4A2 syndrome.

• The paper compares gene expression patterns across multiple animal species.
• It focuses on evolutionary origins of cortical neurons, not human health.
• NR4A2 appears as one of several markers in a comparative anatomy study.
• No clinical data, patient outcomes, or therapeutic insights are included.

Bimodal distribution of RNA expression levels in human skeletal muscle tissue.

Mason CC, Hanson RL, Ossowski V, Bian L, Baier LJ, Krakoff J, Bogardus C

Bimodal gene expression—where gene activity splits into two distinct groups—is extremely rare in healthy human muscle tissue, occurring in less than 0.2% of genes. Most bimodal genes are controlled by nearby genetic variants and are linked to diseases like diabetes, suggesting they may play a direct role in disease development.

• Bimodal gene expression is rare in muscle tissue (<0.2%)
• Bimodal genes are often controlled by nearby DNA variants (eQTLs)
• Several bimodal genes are linked to insulin resistance and diabetes
• This pattern may reveal genes driving disease risk
• Findings may help identify key genetic drivers in complex conditions

Molecular annotation of integrative feeding neural circuits.

Pérez CA, Stanley SA, Wysocki RW, Havranova J, Ahrens-Nicklas R, Onyimba F, Friedman JM

This study maps brain circuits involved in feeding by identifying specific neuron types that express the NR4A2 gene (Nurr1) in mice. It confirms that these neurons are part of complex networks regulating appetite but does not test any treatments or analyze human patients with NR4A2-related syndromes.

• Researchers map feeding circuits using viral tracers in genetically modified mice.
• NR4A2 (Nurr1) is found in amygdala and cortical neurons linked to feeding.
• The study defines a method for identifying molecular markers in neural circuits.
• No human data or clinical implications for NR4A2 syndrome are presented.

Prenatal exposure to nicotine impairs performance of the 5-choice serial reaction time task in adult rats.

Schneider T, Ilott N, Brolese G, Bizarro L, Asherson PJ, Stolerman IP

Prenatal nicotine exposure causes lasting attention and impulsivity deficits in adult rats, accompanied by increased D5 dopamine receptor expression in the striatum. The study finds no changes in NR4A2 gene expression or other key dopaminergic markers in brain regions relevant to ADHD-like behaviors.

• Prenatal nicotine exposure impairs attention and increases impulsivity in adult rats.
• The study reports no change in NR4A2 gene expression in the striatum or prefrontal cortex.
• D5 dopamine receptor expression increases, but other dopaminergic genes remain unaffected.
• Findings suggest direct effects of nicotine on attention circuits independent of NR4A2.

Acoustic microstreaming increases the efficiency of reverse transcription reactions comprising single-cell quantities of RNA.

Boon WC, Petkovic-Duran K, White K, Tucker E, Albiston A, Manasseh R, Horne MK, Aumann TD

A new acoustic mixing technique significantly improves the detection of rare RNA molecules from single cells, including the NR4A2-related gene Nurr1. This method makes it possible to reliably measure low-abundance transcripts that are usually too scarce to detect in standard single-cell analyses.

• Acoustic micromixing boosts reverse transcription efficiency for tiny RNA amounts.
• It enables reliable detection of the low-abundance Nurr1 transcript from single cells.
• The improvement is most significant when RNA concentrations are extremely low.
• This is a laboratory technique, not a treatment or clinical finding.

NR4All in the vessel wall.

van Tiel CM, de Vries CJ

This review describes how NR4A2 (Nurr1) and related proteins regulate blood vessel health and disease processes like atherosclerosis. It does not provide information on NR4A2-related syndrome, developmental outcomes, or treatments for children.

• NR4A2 regulates vascular physiology in endothelial, smooth muscle, and immune cells.
• The paper focuses on adult cardiovascular diseases like atherosclerosis and restenosis.
• No data is presented regarding pediatric neurodevelopmental conditions or NR4A2 syndrome.
• The content is limited to molecular mechanisms in blood vessel walls.

Effect of Bushen Huoxue Decoction on the orphan receptor and tyrosine hydroxylase in the brain of rats with Parkinson's disease.

Yang MH, Wang HM, Liu Y

Bushen Huoxue Decoction improves motor symptoms and increases Nurr1 and tyrosine hydroxylase levels in rats with Parkinson's disease. This preclinical study demonstrates that the herbal treatment promotes neuronal repair and dopamine pathway activity in an animal model.

• The herbal decoction significantly reduced abnormal rotation behavior in Parkinsonian rats.
• Treatment increased Nurr1 mRNA expression compared to untreated controls.
• Tyrosine hydroxylase positive cells, indicating dopamine neurons, were higher in treated rats.
• Results suggest the herb promotes repair of injured substantia nigra neurons.

Nr4a1 siRNA expression attenuates α-MSH regulated gene expression in 3T3-L1 adipocytes.

Wang SC, Myers SA, Eriksson NA, Fitzsimmons RL, Muscat GE

This study shows that the NR4A1 protein (Nur77) is essential for the effects of a hormone called NDP-MSH on fat cells, including changes in genes linked to inflammation, metabolism, and glucose use. Blocking NR4A1 with a gene-silencing tool stops these changes, suggesting NR4A1 is a key player in how this hormone regulates fat cell function.

• NR4A1 (Nur77) is required for hormone effects on fat cells
• Blocking NR4A1 stops changes in inflammation and metabolism genes
• NR4A1 helps control glucose use in fat cells
• Hormone signaling in fat cells involves NR4A1 and cAMP pathways
• Findings may inform treatments targeting metabolic issues

Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection.

McCoy MT, Jayanthi S, Wulu JA, Beauvais G, Ladenheim B, Martin TA, Krasnova IN, Hodges AB, Cadet JL

Chronic methamphetamine exposure reduces Nr4a2 (Nurr1) levels in rat brains, and an acute dose further decreases them rather than restoring normal function. This study uses a drug abuse model in rats to show how chronic stimulation suppresses key genes, which does not directly inform treatment for NR4A2-related syndrome.

• Chronic methamphetamine lowers Nr4a2 (Nurr1) mRNA in rat striatum.
• An acute methamphetamine dose further reduces Nr4a2 levels instead of normalizing them.
• The study models drug addiction mechanisms, not NR4A2 syndrome pathology.
• Findings are preclinical and do not suggest a therapy for humans.

HDAC3 is a critical negative regulator of long-term memory formation.

McQuown SC, Barrett RM, Matheos DP, Post RJ, Rogge GA, Alenghat T, Mullican SE, Jones S, Rusche JR, Lazar MA, Wood MA

Inhibiting the enzyme HDAC3 enhances long-term memory in mice by increasing the expression of the gene Nr4a2. This study identifies a specific molecular pathway where HDAC3 normally suppresses Nr4a2, which is essential for memory formation.

• HDAC3 inhibition boosts long-term memory in mouse hippocampus models.
• Blocking HDAC3 increases histone acetylation and Nr4a2 gene expression.
• Nr4a2 is required for the memory enhancement caused by HDAC3 inhibition.
• The study uses genetic deletion and pharmacological inhibitors in mice.

Contexts for dopamine specification by calcium spike activity in the CNS.

Velázquez-Ulloa NA, Spitzer NC, Dulcis D

This study uses frog embryos to show that early electrical activity in developing neurons influences whether they become dopamine-producing cells, depending on their specific molecular environment. It identifies distinct subpopulations of neurons with different responses to this activity and suggests these mechanisms could inform future methods for growing replacement neurons in the lab.

• Early electrical spikes help determine if developing neurons become dopamine-producing.
• Different brain regions respond differently to changes in this electrical activity.
• Neurons already expressing GABA are most likely to switch to dopamine production.
• Findings may guide protocols for creating replacement neurons from stem cells.

Reduced NR4A gene dosage leads to mixed myelodysplastic/myeloproliferative neoplasms in mice.

Ramirez-Herrick AM, Mullican SE, Sheehan AM, Conneely OM

Reducing the dosage of NR4A1 and NR4A3 in mice causes blood cancers resembling myelodysplastic/myeloproliferative neoplasms. This study identifies specific genes involved in this process but does not address NR4A2 or human neurological conditions.

• The study focuses on NR4A1 and NR4A3, not the NR4A2 gene relevant to your child.
• Researchers used mice to model blood cancers, not neurological disorders.
• No findings apply to human patients or current treatments for NR4A2 syndrome.

The nuclear orphan receptor Nr4a2 induces Foxp3 and regulates differentiation of CD4+ T cells.

Sekiya T, Kashiwagi I, Inoue N, Morita R, Hori S, Waldmann H, Rudensky AY, Ichinose H, Metzger D, Chambon P, Yoshimura A

This study identifies Nr4a2 as a key regulator of immune system balance, specifically controlling the development and function of regulatory T cells that prevent inflammation. It demonstrates that Nr4a2 directly activates Foxp3 to maintain these protective immune cells and prevents harmful inflammatory responses.

• Nr4a2 directly binds to and activates the Foxp3 gene in immune cells.
• Nr4a2 promotes regulatory T cell development and suppressive function.
• Loss of Nr4a2 leads to increased inflammation and colitis in models.
• The research focuses on immune tolerance rather than neurological function.

Retinoid X receptor α acts as a negative regulator in Nurr1-induced dopaminergic differentiation in rat neural precursor cells.

This study shows that Retinoid X receptor alpha suppresses the ability of Nurr1 to help rat neural precursor cells become dopamine-producing neurons. The findings are limited to rat cell cultures and do not provide direct evidence for human treatment strategies.

• Retinoid X receptor alpha inhibits Nurr1-driven dopaminergic differentiation in rat cells.
• The research uses rat neural precursor cells, not human tissue or patients.
• No clinical data or human genetic findings are presented.
• The mechanism is preclinical and does not suggest an immediate therapy.

Retinoid X receptor α acts as a negative regulator in Nurr1-induced dopaminergic differentiation in rat neural precursor cells.

Yoon EH, Lee KJ, Kim YS, Chang MS, Lee SH, Park CH

RXRα suppresses the ability of Nurr1 to promote dopaminergic neuron development in rat neural precursor cells. This interaction reduces the activity of the TH promoter, which is critical for dopamine production.

• RXRα acts as a negative regulator of Nurr1-induced dopaminergic differentiation.
• Forced RXRα expression significantly reduces Nurr1 activity in rat neural precursor cells.
• The RXRα-Nurr1 heterodimer represses tyrosine hydroxylase promoter activity.
• Disrupted dimeric binding alters this regulatory repression mechanism.